Complete and Durable Response to Combined Chemo/Radiation Therapy in <i>EGFR</i> Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases

Complete and Durable Response to Combined Chemo/Radiation Therapy in <i>EGFR</i> Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases

Most non-small-cell lung cancer (NSCLC) patients are likely to develop brain metastases during the course of their illness. Currently, no consensus on NSCLC patients&#8217; treatment with brain metastasis has been established. Although whole brain radiotherapy prolongs the median survival time o...

Full description

Bibliographic Details
Main Authors: Davide Adriano Santeufemia, Giuseppe Palmieri, Antonio Cossu, Valli De Re, Laura Caggiari, Mariangela De Zorzi, Milena Casula, Maria Cristina Sini, Giovanni Baldino, Maria Filomena Dedola, Giuseppe Corona, Gianmaria Miolo
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Diagnostics
Subjects:
lung cancer
<i>EGFR</i>
brain metastases
radiotherapy
chemotherapy
<i>CDH1</i>
<i>TP53</i>
tumor mutational burden
Online Access:https://www.mdpi.com/2075-4418/9/2/42

Internet

https://www.mdpi.com/2075-4418/9/2/42

Similar Items